US Oncology Spokane, Cancer Care Northwest — Spokane, Washington

US Oncology Spokane, Cancer Care Northwest is a clinical research site located in Spokane, Washington, United States 99218.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

US Oncology Spokane, Cancer Care Northwest has participated in 1 clinical trials.

Therapeutic areas: Malignant Melanoma.

Sponsors: AmpliMed Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology Spokane, Cancer Care Northwest?

US Oncology Spokane, Cancer Care Northwest has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology Spokane, Cancer Care Northwest conducted?

US Oncology Spokane, Cancer Care Northwest has 1 clinical trials on record. Their work covers Malignant Melanoma.

Is US Oncology Spokane, Cancer Care Northwest accredited by Crixeo Health?

US Oncology Spokane, Cancer Care Northwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology Spokane, Cancer Care Northwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.